Dalian Bomei Pharmaceutical

Dalian Bomei Pharmaceutical Co., Ltd. is a China-based pharmaceutical company that focuses on the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 2002 and headquartered in Dalian, the company has built a robust portfolio centered on cardiovascular, metabolic, and neurological health. Their flagship products include alprostadil and L-carnitine, which are produced in state-of-the-art facilities that meet global Good Manufacturing Practice (GMP) standards. Dalian Bomei operates as both an independent drug developer and a contract manufacturer, leveraging its expertise in chemical synthesis and sterile injection production. The company serves a diverse range of markets, providing essential medications to healthcare providers across China and internationally. Through continuous innovation in formulation and process chemistry, Dalian Bomei maintains a competitive position in the specialty generics and API supply chain.